Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04323046
Title Immunotherapy (Nivolumab and Ipilimumab) Before and After Surgery for the Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sabine Mueller, MD, PhD
Indications

high grade glioma

Therapies

Ipilimumab

Ipilimumab + Nivolumab

Nivolumab

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.